The Indian government has taken immediate and decisive action to control the export of unapproved combination drugs containing Tapentadol and Carisoprodol manufactured by Aveo Pharmaceuticals, Mumbai, to certain countries in West Africa, the ministry of health and family welfare said in a statement. The ministry said that in January, the Central Drugs Standard Control Organisation (CDSCO), in collaboration with state regulators, had focused on auditing firms manufacturing and exporting drugs covered by the Narcotic Drugs and Psychotropic Substances Act 1985. “Based on analysis of observations from the audit, important decisions were taken to strengthen regulatory oversight on export of NDPS drugs from India,” the health ministry said in its statement. As part of the exercise, a joint team from the CDSCO and the state regulatory authorities conducted a comprehensive audit of Aveo Pharmaceuticals between 21 and 22 February 2025.
